Weight Loss Drugs

About this episode

The episode discusses the use of weight loss drugs like mounjaro and ozempic, their effectiveness, and the implications for health insurance.

Hi everyone, we are back and talking about the use of weight loss drugs and getting protection insurance. Millions of people in the UK are now taking drugs like mounjaro and ozempic, to help them reach a healthy weight. Health professionals and insurers have said for many years that having a higher BMI isn’t healthy and can lead to long-term health complications. Weight loss drugs are proving to be a highly effective way for people to lose weight, which is generally seen as a good thing. But, there are side effects to taking the drugs too and at the moment there is very little long-term data to know what this may mean for someone 5, 10, 15 or 20 years down the line. The key takeaways: The use of weight loss drugs is showing very positive results from short-term data There is not enough long-term data around the use of mounjaro, ozempic, or other weight loss drugs, for insurers to completely understand client risks Two case studies of arranging life insurance for people who are taking or have taken mounjaro It has been a super intense start to the year, we were caught in the snow and school snow days have certainly had an impact on my timings. At this moment I’m not sure what the…

People in this episode

Host: Kathryn Knowles

Topics covered

• weight loss drugs
• health insurance
• BMI
• long-term health
• case studies

Keywords

• weight loss
• insurance
• mounjaro
• ozempic
• BMI
• health complications
• long-term data

Sponsors

PlannerX

Mentioned in this episode

Products: mounjaro, ozempic

Places: UK

More episodes of The Practical Protection Podcast

• Underdisclosure · June 11, 2026 · 50 min
• Overdisclosure · May 28, 2026 · 34 min
• Fatty Liver Disease · May 14, 2026 · 32 min
• The Value of Lasting Power of Attorneys · April 30, 2026 · 42 min
• FCA Protection Market Study · February 19, 2026 · 40 min
• Vulnerable Clients · February 5, 2026 · 44 min